Key facts
- Hytro’s last known valuation is $10.0M (Jul 2025).
- It has raised $4.5M; the latest was Later Stage VC in Jul 2025.
- Notable investors include The FSE Group, Lince Capital, Brinyhold, Cameron Norrie, Casey Toohill — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Hytro
- ·The full record, as it builds
Funding rounds
No funding rounds for Hytro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hytro
Developer of a wearable device designed to help athletes build muscle and recover efficiently. The company's device allows oxygenated blood to flow to the muscles but restricts the amount that then returns to the heart, enabling athletes to enhance muscle size and strength and improve sports performance.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Surrey, United Kingdom
- Founded
- 2018
- Employees
- 5
- Website
- hytro.com/
- Ownership
- Privately Held (backing)
Hytro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hytro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hytro in its N-PORT filings yet. We sweep new filings monthly.